<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

Nelfinavir mesylate - AG 1343

產(chǎn)品貨號(hào)

Axon 1553 CAS [159989-65-8] MF C32H45N3O4S.CH4O3SMW 663.89 Purity: 99% Soluble in DMSO Description Orally active HIV protease inhibitor, with KI values to be 2nM (HIV-1) References Certificates Categories Extra info P Pyrko. HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress. Cancer Res. 2007, 67,?10920–8.? ? JJ Gills et al. Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo. Clin. Cancer Res. 2007,?13(17), 5183–5194. ? WA Chow et al. Anti-HIV drugs for cancer therapeutics: back to the future?. Lancet Oncol. 2009, 10 (1), 61–71.? Certificate of Analysis Material Safety Data Sheet Immunology HIV-1 Protease EC 3.4.23.16 Pfizer Licensed Products HIV-1 protease inhibitor Chemical name (3S,4aS,8aS)-N-tert-butyl-2-((2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl)decahydroisoquinoline-3-carboxamide methanesulfonate Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [159989-64-7] Order Size Unit Price Stock 10 mg €90.00 In Stock

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

Nelfinavir mesylate - AG 1343

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 1553

CAS [159989-65-8]

MF C32H45N3O4S.CH4O3S
MW 663.89

Purity: 99%
Soluble in DMSO

Nelfinavir mesylate

Description

Orally active HIV protease inhibitor, with KI values to be 2nM (HIV-1)

P Pyrko. HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress. Cancer Res. 2007, 67,?10920–8.?

JJ Gills et al. Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo. Clin. Cancer Res. 2007,?13(17), 5183–5194.

WA Chow et al. Anti-HIV drugs for cancer therapeutics: back to the future?. Lancet Oncol. 2009, 10 (1), 61–71.?

Certificate of Analysis
Material Safety Data Sheet

Immunology HIV-1 Protease EC 3.4.23.16 Pfizer Licensed Products

HIV-1 protease inhibitor

Chemical name

(3S,4aS,8aS)-N-tert-butyl-2-((2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl)decahydroisoquinoline-3-carboxamide methanesulfonate

Source information

Pfizer compound; Sold for research purposes under agreement from Pfizer Inc.

Parent CAS No.

[159989-64-7]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>